Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

A Randomized, Controlled, Phase 2 Study of Maralixibat in the Treatment of Itching Associated With Primary Biliary Cholangitis.

Mayo MJ, Pockros PJ, Jones D, Bowlus CL, Levy C, Patanwala I, Bacon B, Luketic V, Vuppalanchi R, Medendorp S, Dorenbaum A, Kennedy C, Novak P, Gu J, Apostol G, Hirschfield GM.

Hepatol Commun. 2019 Feb 1;3(3):365-381. doi: 10.1002/hep4.1305. eCollection 2019 Mar.

2.

Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents.

Hagerman R, Jacquemont S, Berry-Kravis E, Des Portes V, Stanfield A, Koumaras B, Rosenkranz G, Murgia A, Wolf C, Apostol G, von Raison F.

Sci Rep. 2018 Nov 19;8(1):16970. doi: 10.1038/s41598-018-34978-4.

3.

Drug development for neurodevelopmental disorders: lessons learned from fragile X syndrome.

Berry-Kravis EM, Lindemann L, Jønch AE, Apostol G, Bear MF, Carpenter RL, Crawley JN, Curie A, Des Portes V, Hossain F, Gasparini F, Gomez-Mancilla B, Hessl D, Loth E, Scharf SH, Wang PP, Von Raison F, Hagerman R, Spooren W, Jacquemont S.

Nat Rev Drug Discov. 2018 Apr;17(4):280-299. doi: 10.1038/nrd.2017.221. Epub 2017 Dec 8. Review.

PMID:
29217836
4.

Mavoglurant in adolescents with fragile X syndrome: analysis of Clinical Global Impression-Improvement source data from a double-blind therapeutic study followed by an open-label, long-term extension study.

Bailey DB Jr, Berry-Kravis E, Wheeler A, Raspa M, Merrien F, Ricart J, Koumaras B, Rosenkranz G, Tomlinson M, von Raison F, Apostol G.

J Neurodev Disord. 2016;8:1. doi: 10.1186/s11689-015-9134-5. Epub 2015 Dec 15.

5.

Mavoglurant in fragile X syndrome: Results of two randomized, double-blind, placebo-controlled trials.

Berry-Kravis E, Des Portes V, Hagerman R, Jacquemont S, Charles P, Visootsak J, Brinkman M, Rerat K, Koumaras B, Zhu L, Barth GM, Jaecklin T, Apostol G, von Raison F.

Sci Transl Med. 2016 Jan 13;8(321):321ra5. doi: 10.1126/scitranslmed.aab4109.

PMID:
26764156
6.

Development of mavoglurant and its potential for the treatment of fragile X syndrome.

Gomez-Mancilla B, Berry-Kravis E, Hagerman R, von Raison F, Apostol G, Ufer M, Gasparini F, Jacquemont S.

Expert Opin Investig Drugs. 2014 Jan;23(1):125-34. doi: 10.1517/13543784.2014.857400. Epub 2013 Nov 20. Review.

PMID:
24251408
7.

The challenges of clinical trials in fragile X syndrome.

Jacquemont S, Berry-Kravis E, Hagerman R, von Raison F, Gasparini F, Apostol G, Ufer M, Des Portes V, Gomez-Mancilla B.

Psychopharmacology (Berl). 2014 Mar;231(6):1237-50. doi: 10.1007/s00213-013-3289-0. Epub 2013 Oct 31. Review.

8.

A randomized, double-blind, placebo-controlled phase 2 study of α4β2 agonist ABT-894 in adults with ADHD.

Bain EE, Robieson W, Pritchett Y, Garimella T, Abi-Saab W, Apostol G, McGough JJ, Saltarelli MD.

Neuropsychopharmacology. 2013 Feb;38(3):405-13. doi: 10.1038/npp.2012.194. Epub 2012 Oct 3.

9.

A randomized pilot study of the efficacy and safety of ABT-089, a novel α4β2 neuronal nicotinic receptor agonist, in adults with attention-deficit/hyperactivity disorder.

Bain EE, Apostol G, Sangal RB, Robieson WZ, McNeill DL, Abi-Saab WM, Saltarelli MD.

J Clin Psychiatry. 2012 Jun;73(6):783-9. doi: 10.4088/JCP.10m06719.

PMID:
22795204
10.

Efficacy and safety of the novel α₄β₂ neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study.

Apostol G, Abi-Saab W, Kratochvil CJ, Adler LA, Robieson WZ, Gault LM, Pritchett YL, Feifel D, Collins MA, Saltarelli MD.

Psychopharmacology (Berl). 2012 Feb;219(3):715-25. doi: 10.1007/s00213-011-2393-2. Epub 2011 Jul 12.

PMID:
21748252
11.

Safety and efficacy of ABT-089 in pediatric attention-deficit/hyperactivity disorder: results from two randomized placebo-controlled clinical trials.

Wilens TE, Gault LM, Childress A, Kratochvil CJ, Bensman L, Hall CM, Olson E, Robieson WZ, Garimella TS, Abi-Saab WM, Apostol G, Saltarelli MD.

J Am Acad Child Adolesc Psychiatry. 2011 Jan;50(1):73-84.e1. doi: 10.1016/j.jaac.2010.10.001. Epub 2010 Nov 25.

12.

Associations of lipoprotein lipase gene polymorphisms with longitudinal plasma lipid trends in young adults: The Coronary Artery Risk Development in Young Adults (CARDIA) study.

Tang W, Apostol G, Schreiner PJ, Jacobs DR Jr, Boerwinkle E, Fornage M.

Circ Cardiovasc Genet. 2010 Apr;3(2):179-86. doi: 10.1161/CIRCGENETICS.109.913426. Epub 2010 Feb 11.

13.

Divalproex sodium extended-release for the prophylaxis of migraine headache in adolescents: results of a stand-alone, long-term open-label safety study.

Apostol G, Lewis DW, Laforet GA, Robieson WZ, Fugate JM, Abi-Saab WM, Saltarelli MD.

Headache. 2009 Jan;49(1):45-53. doi: 10.1111/j.1526-4610.2008.01279.x. Epub 2008 Nov 14.

PMID:
19040679
14.

Safety and tolerability of divalproex sodium extended-release in the prophylaxis of migraine headaches: results of an open-label extension trial in adolescents.

Apostol G, Pakalnis A, Laforet GA, Robieson WZ, Olson E, Abi-Saab WM, Saltarelli M.

Headache. 2009 Jan;49(1):36-44. doi: 10.1111/j.1526-4610.2008.01299.x. Epub 2008 Nov 24.

PMID:
19040678
15.

Divalproex extended-release in adolescent migraine prophylaxis: results of a randomized, double-blind, placebo-controlled study.

Apostol G, Cady RK, Laforet GA, Robieson WZ, Olson E, Abi-Saab WM, Saltarelli M.

Headache. 2008 Jul;48(7):1012-25.

PMID:
18705027
16.

Longitudinal association of body mass index with lung function: the CARDIA study.

Thyagarajan B, Jacobs DR Jr, Apostol GG, Smith LJ, Jensen RL, Crapo RO, Barr RG, Lewis CE, Williams OD.

Respir Res. 2008 Apr 4;9:31. doi: 10.1186/1465-9921-9-31.

17.

Plasma fibrinogen and lung function: the CARDIA Study.

Thyagarajan B, Jacobs DR, Apostol GG, Smith LJ, Lewis CE, Williams OD.

Int J Epidemiol. 2006 Aug;35(4):1001-8. Epub 2006 Mar 22.

PMID:
16554379
18.

Early life factors contribute to the decrease in lung function between ages 18 and 40: the Coronary Artery Risk Development in Young Adults study.

Apostol GG, Jacobs DR Jr, Tsai AW, Crow RS, Williams OD, Townsend MC, Beckett WS.

Am J Respir Crit Care Med. 2002 Jul 15;166(2):166-72.

PMID:
12119228
19.

Fourier transform infrared assay of liposomal lipids.

Pidgeon C, Apostol G, Markovich R.

Anal Biochem. 1989 Aug 15;181(1):28-32.

PMID:
2817380
20.

[Esophageal atresia; genetic and epidemiological studies].

Apostol G, Pesamosca A, Duca D.

Rev Pediatr Obstet Ginecol Pediatr. 1983 Jul-Sep;32(3):219-29. Romanian. No abstract available.

PMID:
6419325
21.

Gastric haemangiopericytoma with glomus-like pattern and review of the literature.

Hălălău F, Apostol G, Chirculescu AR.

Morphol Embryol (Bucur). 1981 Oct-Dec;27(4):359-61.

PMID:
6460174
23.
24.

Reduced food intake following cerebral intraventricular infusion of glucose in Gallus domesticus.

Matei-Vladescu C, Apostol G, Popescu V.

Physiol Behav. 1977 Jul;19(1):7-10.

PMID:
11803694
25.

Effects of cerebral lateral, ventricular infusions of phloridzin on feeding and body weight in Gallus domesticus (L.).

Apostol G, Matei-Vladescu C, Popescu V.

Experientia. 1977 Mar 15;33(3):345-7.

PMID:
858363
26.

Crosscorrelation between the activity of septal units and hippocampal EEG during arousal.

Apostol G, Creutzfeldt OD.

Brain Res. 1974 Feb 15;67(1):65-75. No abstract available.

PMID:
4470418
27.

[Recklinghausen's neurofibromatosis with intrathoracic localization].

Aldea A, Apostol G.

Chirurgia (Bucur). 1973 Feb;22(2):173-6. Romanian. No abstract available.

PMID:
4632241
28.

[Bursting of cecum and right colon in a 6 month old baby].

Bercu G, Strajescu N, Apostol G, Homorodeanu D.

Acta Gastroenterol Belg. 1969 Oct;32(10):778-81. French. No abstract available.

PMID:
5399794
29.

[A case of myeloplax tumor].

Mocanescu F, Apostol G, Bercu G.

Acta Orthop Belg. 1968 Jul-Aug;34(4):593-5. French. No abstract available.

PMID:
5737985
30.

Hippocampal necortical arousal dissociation under reticular and hormonal influences.

Nicolescu-Catargi A, Apostol G, Petrescu S.

Electroencephalogr Clin Neurophysiol. 1967 Jun;22(6):575. No abstract available.

PMID:
4165002
31.

Alterations in hippocampal activity in the rabbit in terms of blood adrenalin and cortisone levels.

Nicolescu-Catargi A, Apostol G.

Electroencephalogr Clin Neurophysiol. 1967 Jun;22(6):574-5. No abstract available.

PMID:
4165001
32.

[Apropos of a case of gastric lipoma].

Sträjescu E, Ganea Z, Bercu G, Homorodeanu I, Vladescu N, Apostol G.

Lyon Chir. 1967 Mar;63(2):264-5. French. No abstract available.

PMID:
5609736
33.

[Changes in the electroencephalogram during orienting and food procuring reflexes to a chain stimulus in rabbits].

Voronin LG, Apostol G, Kaliuzhnyĭ LV.

Zh Vyssh Nerv Deiat Im I P Pavlova. 1966 May-Jun;16(3):395-403. Russian. No abstract available.

PMID:
6005513
34.

ELECTRICAL ACTIVITY EVOKED IN RABBIT CORTEX BY PAIRED ACOUSTIC AND RHYTHMIC LIGHT STIMULI.

APOSTOL G, VORONIN LG.

Fed Proc Transl Suppl. 1964 May-Jun;23:633-5. No abstract available.

PMID:
14185928
35.

[THE ELECTRICAL ACTIVITY OF THE CEREBRAL CORTEX OF RABBITS DURING PAIRING OF THE ACTION OF SOUND WITH RHYTHMIC LIGHT].

APOSTOL G, VORONIN LG.

Zh Vyssh Nerv Deiat Im I P Pavlova. 1963 Jul-Aug;13:699-704. Russian. No abstract available.

PMID:
14059211

Supplemental Content

Loading ...
Support Center